PubMed · 1999 · 92 citations · 20 references
Life SciencesImmunologyOncologyCancer ImmunologyTumor ImmunologyVaccinologyCancer ImmunotherapyCancer VaccinesCytokines In Tumor ImmunityT Cell Responses To TumorsTumor AntigensTumor-associated AntigensCancer Vaccine DesignCytokine-based Cancer VaccinesGranulocyte Colony-stimulating Factor AdministrationImmune System ModulationTumor Antigen ImmunogenicityTumor Antigen VaccinesTumor ImmunogenicityTumor-associated Antigen Vaccines
We have previously shown that Listeria monocytogenes, a gram-positive, facultative intracellular bacterium, is a potent vector for targeting tumor-specific antigens to the immune system. In the present study, we extend these studies to the highly tumorigenic mouse melanoma B16F10, transduced with a model tumor antigen. We are able to induce the regression of primary tumors and established lung metastases by parenteral immunization with a L. monocytogenes recombinant that expresses the same antigen. Adjunctive therapy with granulocyte macrophage colony-stimulating factor or a vaccinia-based vaccine does not result in an improved cure rate over the L. monocytogenes vaccine alone. Tumor regression is accompanied by the expression of inflammatory cytokines in the tumor.
20
Glen Dranoff, Elizabeth M. Jaffee, A Lazenby et al. · Proceedings of the National Academy of Sciences · 1993 · 2.8K citations
Medicine, Immunology, Oncology +17
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Kenneth E. Hung, Robert J. Hayashi, Anne Lafond-Walker et al. · The Journal of Experimental Medicine · 1998 · 1.3K citations · Full text
Life Sciences, Immunology, Oncology +17
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Alex Y. Huang, Paul T. Golumbek, Mojgan Ahmadzadeh et al. · Science · 1994 · 1.2K citations
Life Sciences, Immunology, Oncology +17